Savannah

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• High blood pressure3 trials
• Chronic kidney disease1 trial

Phase

• Phase 23 trials

Status

• Completed2 trials
• Active, not recruiting1 trial

Lead sponsor

• Alnylam Pharmaceuticals3 trials

Running trials

• Recruiting

  A Study to Evaluate ALN-AGT01 RVR in Adult Patients With Mild to Moderate Hypertension Pretreated With Zilebesiran

  NCT07553442· Phase 2· Alnylam Pharmaceuticals· Source

Closed trials

• Completed

  Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3)

  NCT06272487· Phase 2· Alnylam Pharmaceuticals· Source

• Completed

  Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2)

  NCT05103332· Phase 2· Alnylam Pharmaceuticals· Source